Related Experiment Video
Updated: Dec 13, 2025

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
Imaging of Multiple Myeloma.
Aleksander Kosmala1, Thorsten Bley1, Bernhard Petritsch1
1Department of Diagnostic and Interventional Radiology, University-Hospital Würzburg, Germany.
Advanced imaging techniques like whole-body CT and MRI have surpassed conventional X-rays for diagnosing multiple myeloma and its precursor diseases. These methods are crucial for detecting bone lesions and marrow infiltration, aiding in treatment monitoring.
Area of Science:
- Radiology
- Hematology
- Oncology
Background:
- Multiple myeloma is a plasma cell malignancy impacting bone marrow.
- Accurate diagnosis and monitoring rely heavily on medical imaging.
- Understanding precursor diseases is vital for early intervention.
Purpose of the Study:
- To review multiple myeloma, precursor diseases, and current imaging modalities.
- To discuss the advantages, limitations, and prognostic implications of various imaging techniques.
- To provide an overview of imaging's role in multiple myeloma management.
Main Methods:
- Literature review of multiple myeloma and imaging techniques.
- Analysis of cross-sectional imaging, including CT, MRI, and PET/CT.
- Evaluation of imaging findings in the context of current scientific literature.
Main Results:
- Cross-sectional imaging supersedes conventional X-ray skeletal surveys.
- Whole-body CT effectively detects osteolytic lesions.
- MRI is superior for identifying bone marrow infiltration and staging precursor diseases.
- PET/CT offers functional insights for treatment response evaluation.
Conclusions:
- Conventional X-rays are now considered obsolete for multiple myeloma.
- Whole-body CT is standard for detecting osteolysis.
- MRI is the most sensitive tool for bone marrow assessment and precursor disease evaluation.
- PET/CT is valuable for monitoring treatment efficacy and disease progression.
More Related Videos
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Published on: January 7, 2019
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015